Trivium Point Advisory’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-16,288
Closed -$1.01M 303
2025
Q4
$1.01M Sell
16,288
-1,179
-7% -$72.8K 0.1% 175
2025
Q3
$1.05M Buy
17,467
+13,533
+344% +$828K 0.11% 174
2025
Q2
$246K Sell
3,934
-142,456
-97% -$8.56M 0.03% 308
2025
Q1
$8.81M Buy
146,390
+10,178
+7% +$632K 1.09% 14
2024
Q4
$7.95M Buy
136,212
+4,753
+4% +$282K 1% 17
2024
Q3
$7.89M Buy
131,459
+23,045
+21% +$1.32M 1.1% 14
2024
Q2
$6.08M Buy
108,414
+93,778
+641% +$5.25M 0.91% 22
2024
Q1
$858K Buy
14,636
+9,097
+164% +$514K 0.18% 120
2023
Q4
$299K Buy
+5,539
New +$271K 0.07% 171
2020
Q2
Sell
-5,904
Closed -$237K 162
2020
Q1
$237K Buy
5,904
+354
+6% +$14.9K 0.12% 123
2019
Q4
$245K Sell
5,550
-1,188
-18% -$49.9K 0.1% 147
2019
Q3
$269K Buy
6,738
+1,428
+27% +$58.5K 0.12% 136
2019
Q2
$213K Buy
+5,310
New +$201K 0.09% 155

Other funds holding IHI

Trivium Point Advisory's IHI Position: Q1 2026 in Review

Trivium Point Advisory sold out of iShares US Medical Devices ETF (IHI) in Q1 2026, closing a stake of 16,288 shares — an estimated $1.01M sold.

Trivium Point Advisory first reported a position in IHI in Q2 2019 and held it in 13 quarters. The position peaked at $8.81M in Q1 2025. 503 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Trivium Point Advisory reported no remaining iShares US Medical Devices ETF position as of Q1 2026 after selling out during the quarter.
  • Trivium Point Advisory sold 16,288 iShares US Medical Devices ETF shares in Q1 2026, an estimated $1.01M.
  • Trivium Point Advisory first reported a position in iShares US Medical Devices ETF in Q2 2019 and held it in 13 quarters.
  • Trivium Point Advisory's iShares US Medical Devices ETF position peaked at $8.81M in Q1 2025.
  • 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Trivium Point Advisory's 13F filing for Q1 2026, filed 21 Apr 2026.